KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and ...

Induced pluripotent stem-cell-derived corneal epithelium to treat limbal stem cell deficiency could transform eye care and ...

Dr. Roy Rubinfeld, an internationally renowned corneal surgeon and innovator, has developed a groundbreaking epithelium-on ...

This procedure involves reshaping the cornea, the eye’s clear front surface, to improve how light focuses on the retina.